Cardlytics (NASDAQ:CDLX) CEO Sells $26,936.45 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 6,785 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $3.97, for a total transaction of $26,936.45. Following the completion of the sale, the chief executive officer owned 132,065 shares in the company, valued at approximately $524,298.05. The trade was a 4.89% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Amit Gupta also recently made the following trade(s):

• On Tuesday, August 18th, Amit Gupta sold 6,676 shares of Cardlytics stock. The shares were sold at an average price of $4.03, for a total transaction of $26,904.28.
• On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The shares were sold at an average price of $4.39, for a total transaction of $42,319.60.
• On Thursday, July 2nd, Amit Gupta sold 6,498 shares of Cardlytics stock. The shares were sold at an average price of $4.39, for a total transaction of $28,526.22.

Cardlytics Stock Up 1.7%

NASDAQ CDLX traded up $0.07 during midday trading on Tuesday, hitting $4.12. The company had a trading volume of 53,338 shares, compared to its average volume of 93,274. The firm has a fifty day simple moving average of $4.37 and a two-hundred day simple moving average of $7.04. Cardlytics, Inc. has a fifty-two week low of $3.49 and a fifty-two week high of $32.80. The stock has a market cap of $23.94 million, a price-to-earnings ratio of -0.22 and a beta of 0.62.

Cardlytics (NASDAQ:CDLX) last released its earnings results on Wednesday, August 5th. The company reported ($1.50) earnings per share for the quarter, beating the consensus estimate of ($2.30) by $0.80. Cardlytics had a negative net margin of 55.92% and a negative return on equity of 956.56%. The business had revenue of $36.88 million during the quarter, compared to analysts’ expectations of $37.00 million. As a group, equities analysts predict that Cardlytics, Inc. will post -3.89 earnings per share for the current year.

Institutional Investors Weigh In On Cardlytics

A number of institutional investors have recently added to or reduced their stakes in CDLX. Bank of America Corp DE grew its stake in shares of Cardlytics by 262.7% in the 3rd quarter. Bank of America Corp DE now owns 1,632,786 shares of the company’s stock valued at $3,968,000 after purchasing an additional 1,182,593 shares during the period. UBS Group AG boosted its stake in Cardlytics by 112.5% in the 3rd quarter. UBS Group AG now owns 458,066 shares of the company’s stock valued at $1,113,000 after buying an additional 242,536 shares in the last quarter. Raymond James Financial Inc. grew its position in Cardlytics by 36,915.3% in the third quarter. Raymond James Financial Inc. now owns 133,255 shares of the company’s stock valued at $324,000 after acquiring an additional 132,895 shares during the period. Jane Street Group LLC grew its position in Cardlytics by 263.0% in the second quarter. Jane Street Group LLC now owns 162,427 shares of the company’s stock valued at $267,000 after acquiring an additional 117,687 shares during the period. Finally, Private Advisor Group LLC acquired a new position in Cardlytics during the third quarter worth $272,000. 68.10% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on CDLX shares. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a report on Thursday, June 18th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cardlytics in a research report on Wednesday, July 8th. Wall Street Zen upgraded shares of Cardlytics from a “sell” rating to a “hold” rating in a research note on Saturday, August 8th. Finally, Lake Street Capital set a $10.00 price target on shares of Cardlytics in a report on Friday, May 8th. One equities research analyst has rated the stock with a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Sell” and a consensus target price of $10.00.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.